[1] He J, Zeng Z, Shi S. 119P: Feasibility and efficacy of helical
IMRT for stage Ⅲ non- small cell lung cancer in
comparison with conventionally fractionated 3D- CRT[J].
Journal of Thoracic Oncology, 2016,11(4):S107-S108.
[2] 伍楚蓉,杨文,黄红东,等. 培美曲塞加顺铂诱导化疗联合同期放
化疗对局部晚期非小细胞肺癌的疗效[J].中国老年学杂志,2013,
33(19):4739-4742.
[3] AlessroBaisi,Federico Raveglia,Matilde De Simone,et al.
Recurrence After Radiofrequency Ablation for Stage I Non-
Small Cell Lung Cancer [J]. ANN THORAC SURG,
2012,94(5):1788-1789.
[4] 蒋华勇,王雅杰,贾朝阳,等. 诱导化疗后调强适形放疗治疗局部
进展期非小细胞肺癌临床结果分析[J]. 医学研究杂志,2014,43
(4):95-99.
[5] Miller VA, Hirsh V, Cadranel J, et al. Afatinib versus placebo
for patients with advanced, metastatic non- small- cell
lung cancer after failure of erlotinib, gefitinib, or both,
and one or two lines of chemotherapy (LUX- Lung 1): a
phase 2b/3 randomised trial [J]. The lancet oncology,
2012,13(5):528-538.
[6] 蔡勇,白冲. 适形放疗联合吉非替尼同步治疗局部晚期老年非小
细胞肺癌的疗效[J].中国老年学杂志,2013,33(10):2445-2446.
[7] 储建华,徐杰,沈预程,等. 全脑放疗序贯吉非替尼治疗老年非小
细胞肺癌伴脑转移的临床观察[J].临床肿瘤学杂志,2013,18(7):
656-658.
[8] 方晶,胡丽丽,李宏奇,等. 螺旋断层调强根治性放射治疗同步化
疗治疗Ⅳ期非小细胞肺癌的临床效果研究[J]. 中国医学装备,
2016,13(7):74-77.